BSE Live
Jan 23, 14:28Prev. Close
68.50
Open Price
68.50
Bid Price (Qty.)
66.10 (8)
Offer Price (Qty.)
69.00 (4)
NSE Live
Jan 23, 14:28Prev. Close
68.45
Open Price
68.51
Bid Price (Qty.)
66.50 (1)
Offer Price (Qty.)
68.94 (37)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.54 | 4.94 | 1.67 | 3.79 | 3.34 | |
| Diluted EPS (Rs.) | 4.54 | 4.96 | 1.68 | 3.79 | 3.34 | |
| Cash EPS (Rs.) | 10.68 | 11.08 | 7.49 | 9.95 | 9.60 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 48.63 | 43.82 | 40.60 | 39.46 | 36.00 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 48.63 | 43.82 | 40.60 | 39.46 | 36.00 | |
| Revenue from Operations/Share (Rs.) | 190.37 | 214.64 | 193.89 | 189.72 | 169.02 | |
| PBDIT/Share (Rs.) | 19.95 | 21.75 | 16.61 | 19.31 | 17.27 | |
| PBIT/Share (Rs.) | 13.81 | 15.38 | 10.79 | 13.21 | 10.85 | |
| PBT/Share (Rs.) | 3.23 | 5.72 | 3.03 | 6.20 | 2.77 | |
| Net Profit/Share (Rs.) | 4.55 | 4.71 | 1.67 | 3.85 | 3.18 | |
| NP After MI And SOA / Share (Rs.) | 4.53 | 4.68 | 1.64 | 3.79 | 3.20 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 10.47 | 10.13 | 8.56 | 10.18 | 10.21 | |
| PBIT Margin (%) | 7.25 | 7.16 | 5.56 | 6.96 | 6.41 | |
| PBT Margin (%) | 1.69 | 2.66 | 1.56 | 3.26 | 1.63 | |
| Net Profit Margin (%) | 2.38 | 2.19 | 0.86 | 2.02 | 1.88 | |
| NP After MI And SOA Margin (%) | 2.38 | 2.17 | 0.84 | 1.99 | 1.89 | |
| Return on Networth/Equity (%) | 9.32 | 10.66 | 4.03 | 9.57 | 8.85 | |
| Return on Capital Employed (%) | 18.92 | 20.86 | 16.30 | 20.64 | 18.36 | |
| Return on Assets (%) | 2.14 | 2.31 | 0.82 | 2.15 | 1.97 | |
| Total Debt/Equity (X) | 1.94 | 2.01 | 2.05 | 1.67 | 1.95 | |
| Asset Turnover Ratio (%) | 0.93 | 1.07 | 1.06 | 1.12 | 1.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.07 | 1.15 | 1.09 | 1.11 | 1.08 | |
| Quick Ratio (X) | 0.60 | 0.72 | 0.62 | 0.67 | 0.68 | |
| Inventory Turnover Ratio (X) | 3.18 | 1.95 | 2.08 | 2.43 | 2.12 | |
| Dividend Payout Ratio (NP) (%) | 26.47 | 21.22 | 60.55 | 26.41 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 11.24 | 8.98 | 13.30 | 10.11 | 0.00 | |
| Earnings Retention Ratio (%) | 73.53 | 78.78 | 39.45 | 73.59 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 88.76 | 91.02 | 86.70 | 89.89 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 1.88 | 2.25 | 2.14 | 2.75 | 2.14 | |
| Interest Coverage Ratios (Post Tax) (%) | 1.88 | 2.25 | 2.14 | 2.75 | 2.14 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 274.72 | 270.49 | 228.31 | 252.09 | 180.34 | |
| EV/Net Operating Revenue (X) | 0.91 | 0.80 | 0.75 | 0.90 | 0.72 | |
| EV/EBITDA (X) | 8.65 | 7.87 | 8.76 | 8.81 | 7.05 | |
| MarketCap/Net Operating Revenue (X) | 0.44 | 0.43 | 0.35 | 0.57 | 0.32 | |
| Retention Ratios (%) | 73.52 | 78.77 | 39.44 | 73.58 | 0.00 | |
| Price/BV (X) | 1.71 | 2.08 | 1.65 | 2.73 | 1.49 | |
| Price/Net Operating Revenue | 0.44 | 0.43 | 0.35 | 0.57 | 0.32 | |
| Earnings Yield | 0.05 | 0.05 | 0.02 | 0.04 | 0.06 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y